News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
770,722 Results
Type
Article (53162)
Company Profile (365)
Press Release (717167)
Multimedia
Podcasts (135)
Webinars (25)
Section
Business (213197)
Career Advice (2217)
Deals (36677)
Drug Delivery (143)
Drug Development (85301)
Employer Resources (182)
FDA (17235)
Job Trends (15531)
News (361022)
Policy (34121)
Tag
2027 BioCapital Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (2914)
Academic (1)
Accelerated approval (47)
Adcomms (32)
Allergies (178)
Alliances (52571)
ALS (218)
Alzheimer's disease (1865)
Antibody-drug conjugate (ADC) (479)
Approvals (17577)
Artificial intelligence (712)
Autoimmune disease (295)
Automation (58)
Bankruptcy (372)
Best Places to Work (12047)
BIOSECURE Act (21)
Biosimilars (227)
Biotechnology (240)
Bladder cancer (193)
Brain cancer (75)
Breast cancer (781)
Cancer (6058)
Cardiovascular disease (479)
Career advice (1887)
Career pathing (43)
CAR-T (350)
CDC (62)
Celiac Disease (3)
Cell therapy (971)
Cervical cancer (48)
Clinical research (73419)
Collaboration (2191)
Company closure (7)
Compensation (1394)
Complete response letters (88)
COVID-19 (2900)
CRISPR (117)
C-suite (1162)
Cystic fibrosis (155)
Data (7875)
Decentralized trials (3)
Denatured (36)
Depression (170)
Dermatology (85)
Diabetes (600)
Diagnostics (7409)
Digital health (57)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (346)
Drug pricing (215)
Drug shortages (32)
Duchenne muscular dystrophy (288)
Earnings (94025)
Editorial (71)
Employer branding (21)
Employer resources (160)
Events (125250)
Executive appointments (1129)
FDA (21008)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (15)
Frontotemporal dementia (35)
Funding (1813)
Gene editing (248)
Generative AI (66)
Gene therapy (774)
GLP-1 (1108)
Government (4955)
Grass and pollen (7)
Guidances (411)
Healthcare (20005)
HIV (84)
Huntington's disease (59)
IgA nephropathy (98)
Immunology and inflammation (322)
Immuno-oncology (100)
Indications (181)
Infectious disease (3252)
Inflammatory bowel disease (231)
Inflation Reduction Act (15)
Influenza (143)
Intellectual property (295)
Interviews (359)
IPO (17086)
IRA (51)
Job creations (3810)
Job search strategy (1565)
JPM (67)
Kidney cancer (21)
Labor market (98)
Layoffs (608)
Leadership (45)
Legal (8196)
Liver cancer (106)
Longevity (34)
Lung cancer (801)
Lymphoma (435)
Machine learning (62)
Management (62)
Manufacturing (1070)
MASH (194)
Medical device (14465)
Medtech (14580)
Mergers & acquisitions (20837)
Metabolic disorders (1552)
mRNA (231)
Multiple sclerosis (191)
NASH (19)
Neurodegenerative disease (438)
Neuropsychiatric disorders (111)
Neuroscience (3432)
Neurotech (1)
NextGen: Class of 2026 (6873)
Non-profit (4830)
Now hiring (77)
Obesity (729)
Opinion (312)
Ovarian cancer (222)
Pain (263)
Pancreatic cancer (307)
Parkinson's disease (373)
Partnered (34)
Patents (608)
Patient recruitment (685)
Peanut (65)
People (62047)
Pharmaceutical (71)
Pharmacy benefit managers (34)
Phase 1 (23079)
Phase 2 (32315)
Phase 3 (23959)
Pipeline (8496)
Policy (329)
Postmarket research (2674)
Preclinical (10057)
Press Release (71)
Prostate cancer (306)
Psychedelics (60)
Radiopharmaceuticals (346)
Rare diseases (1119)
Real estate (6292)
Recruiting (74)
Regulatory (26468)
Reports (57)
Research institute (2658)
Resumes & cover letters (372)
Rett syndrome (36)
RNA editing (22)
RSV (93)
Schizophrenia (182)
Series A (310)
Series B (223)
Service/supplier (12)
Sickle cell disease (120)
Special edition (30)
Spinal muscular atrophy (175)
Sponsored (50)
Startups (3906)
State (2)
Stomach cancer (21)
Supply chain (132)
Tariffs (90)
The Weekly (96)
Vaccines (1151)
Venture capital (117)
Weight loss (478)
Women's health (125)
Worklife (21)
Date
Last 7 days (989)
Last 30 days (3215)
Last 365 days (31484)
2026 (12081)
2025 (31622)
2024 (36730)
2023 (41609)
2022 (52857)
2021 (57459)
2020 (56010)
2019 (48647)
2018 (36755)
2017 (33861)
2016 (33480)
2015 (39577)
2014 (33239)
2013 (28821)
2012 (30889)
2011 (31299)
2010 (29312)
Location
Africa (815)
Alabama (94)
Alaska (7)
Arizona (361)
Arkansas (16)
Asia (42907)
Australia (7277)
California (13395)
Canada (3768)
China (1391)
Colorado (576)
Connecticut (580)
Delaware (404)
Europe (95564)
Florida (1982)
Georgia (439)
Hawaii (3)
Idaho (65)
Illinois (1073)
India (91)
Indiana (617)
Iowa (24)
Japan (537)
Kansas (136)
Kentucky (54)
Louisiana (43)
Maine (88)
Maryland (1618)
Massachusetts (9699)
Michigan (380)
Minnesota (732)
Mississippi (7)
Missouri (147)
Montana (36)
Nebraska (30)
Nevada (145)
New Hampshire (89)
New Jersey (3519)
New Mexico (33)
New York (3510)
North Carolina (1772)
North Dakota (10)
Northern California (6649)
Ohio (399)
Oklahoma (23)
Oregon (43)
Pennsylvania (2667)
Puerto Rico (30)
Rhode Island (51)
South America (1212)
South Carolina (87)
South Dakota (2)
Southern California (5282)
Tennessee (215)
Texas (2152)
United States (47597)
Utah (402)
Vermont (1)
Virginia (322)
Washington D.C. (83)
Washington State (1096)
West Virginia (4)
Wisconsin (148)
Wyoming (2)
770,722 Results for "advanced cell diagnostics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Venture capital
Lilly-Backed China Startup Debuts With $68.7M Seed to Advance Next-Gen T Cell Engagers
Excalipoint Therapeutics will use its seed money to advance a pipeline of cancer therapies, including a tri-specific antibody for small cell lung cancer and neuroendocrine tumors.
March 18, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Takara Bio USA, Inc. Launches Certified Service Provider Program to Advance Research Using NGS and Single-Cell Technologies
April 17, 2026
·
5 min read
Press Releases
Thermo Fisher Scientific Unveils an Integrated Platform to Advance Scalable Cell Therapy Manufacturing
May 4, 2026
·
3 min read
Press Releases
10x Genomics to Advance Research in Diagnostic Applications of Tumor Single Cell and Spatial Profiling
January 13, 2026
·
7 min read
Sponsored
Powering the Next Wave of Cell Therapy: From iPSC-Derived Cells to In Vivo Reprogramming
As cell therapy advances toward clinical reality, iPSC-derived cellular products, in vivo reprogramming strategies, and manufacturing-ready reagent platforms are reshaping regenerative medicine and oncology. Recombinant antibodies and drug targets, e.g. endotoxin-free proteins, transmembrane proteins, and site-specifically labeled biomolecules are emerging as indispensable enablers of reproducibility, mechanistic insight, and clinical-scale success.
March 23, 2026
·
4 min read
Press Releases
Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies
April 20, 2026
·
6 min read
Press Releases
Senti Biosciences Announces Publication in Cell Systems Demonstrating Advanced Logic-Gated CAR Design for Cell Therapies
April 2, 2026
·
4 min read
Press Releases
Boston Cell Standards Enters Final Phase of FDA MDDT Program to Qualify First-in-Industry Platform to Standardize Cancer Diagnostic Assays
April 27, 2026
·
4 min read
Layoffs
50 employees impacted as Astellas closes Universal Cells’ Seattle office
By closing the Universal Cells Seattle location, Astellas is reportedly consolidating cell therapy, gene therapy and oncology research at its South San Francisco, California, and Westborough, Massachusetts, sites.
April 14, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
April 30, 2026
·
6 min read
1 of 77,073
Next